Germline mutations in ATM and BRCA1/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death

Authors:
  • MHM. Han
    M. Han
  • HYH. Yu
    H. Yu
  • DJD. Jiang
    D. Jiang
  • SSS. Shah
    S. Shah
  • CEC. Ewing
    C. Ewing
  • LZL. Zhang
    L. Zhang
  • KNK. Novakovic
    K. Novakovic
  • JPJ. Petkewicz
    J. Petkewicz
  • KGK. Gulukota
    K. Gulukota
  • DHD. Helseth
    D. Helseth

Abstract
No abstract available